KORU Medical Systems (NASDAQ:KRMD) Price Target Raised to $5.00

KORU Medical Systems (NASDAQ:KRMD) had its price objective boosted by Craig Hallum from $4.00 to $5.00 in a research report sent to investors on Thursday,Benzinga reports. They currently have a buy rating on the stock.

Other research analysts have also issued research reports about the company. Canaccord Genuity Group upped their price target on KORU Medical Systems from $3.00 to $4.00 and gave the company a “buy” rating in a research report on Thursday. Piper Sandler upped their price target on KORU Medical Systems from $3.00 to $3.50 and gave the stock an “overweight” rating in a research note on Thursday. Finally, B. Riley assumed coverage on KORU Medical Systems in a research note on Thursday, July 25th. They set a “buy” rating and a $4.00 target price on the stock.

KORU Medical Systems Price Performance

KRMD opened at $3.17 on Thursday. The stock has a 50-day moving average price of $2.67 and a 200-day moving average price of $2.48. KORU Medical Systems has a 12-month low of $1.98 and a 12-month high of $3.40. The company has a current ratio of 2.99, a quick ratio of 3.27 and a debt-to-equity ratio of 0.01.

Hedge Funds Weigh In On KORU Medical Systems

A number of institutional investors have recently bought and sold shares of KRMD. Lakewood Asset Management LLC raised its holdings in KORU Medical Systems by 13.9% during the second quarter. Lakewood Asset Management LLC now owns 68,225 shares of the company’s stock valued at $181,000 after acquiring an additional 8,300 shares during the period. Aaron Wealth Advisors LLC purchased a new position in KORU Medical Systems in the second quarter worth about $28,000. Allspring Global Investments Holdings LLC purchased a new position in KORU Medical Systems in the second quarter worth about $28,000. XTX Topco Ltd purchased a new position in shares of KORU Medical Systems during the third quarter valued at approximately $34,000. Finally, Legato Capital Management LLC purchased a new position in shares of KORU Medical Systems during the second quarter valued at approximately $35,000. 58.60% of the stock is owned by institutional investors.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.